Vishram-Nielsen, Julie K. K. http://orcid.org/0000-0003-1762-7750
Foroutan, Farid http://orcid.org/0000-0002-1029-1812
Rizwan, Saima
Peck, Serena S.
Bodack, Julia
Orchanian-Cheff, Ani http://orcid.org/0000-0002-9943-2692
Gustafsson, Finn http://orcid.org/0000-0003-2144-341X
Ross, Heather J. http://orcid.org/0000-0003-4384-3027
Fan, Eddy http://orcid.org/0000-0002-1210-9914
Rao, Vivek http://orcid.org/0000-0003-1920-0937
Billia, Filio http://orcid.org/0000-0002-2824-1215
Alba, Ana Carolina http://orcid.org/0000-0003-2744-2696
Article History
Accepted: 27 September 2022
First Online: 7 October 2022
Declarations
:
: Not applicable.
: Dr. Finn Gustafsson reports receiving personal fees from Abbott, Novartis, Boehringer-Ingelheim, Pfizer, Bayer, Astra-Zeneca, Pharmacosmos, Alnylam, and Ionis, all outside of the submitted work. EF reports personal fees from ALung Technologies, Aerogen, Baxter, GE Healthcare, Inspira, and Vasomune outside the submitted work. Drs. Julie KK Vishram-Nielsen, Farid Foroutan, Saima Rizwan, Heather J Ross, Eddy Fan, Vivek Rao, Filio Billia, and Ana Carolina Alba, as well as Serena S Peck, Julia Bodack, and Ani Orchanian-Cheff, have no conflicts of interest or financial ties to disclose.
Free to read: This content has been made available to all.